Login to Your Account



Six hospitalized in Bial clinical trial in France; ANSM launches investigation

By John Brosky and Cormac Sheridan
Staff Writers

Friday, January 15, 2016

PARIS – French regulators are investigating a phase I trial of small-molecule candidate BIA 10-2474 after one volunteer was pronounced brain dead and five others hospitalized with identical neurological symptoms at the University Hospital Center of Rennes in France.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription